BioNTech SE (BNTX) Notes Payables (2019 - 2025)

BioNTech SE has reported Notes Payables for 5 years, with the latest figure at $2.5 million in Q4 2023.

• Quarterly Notes Payables rose 15.5% year-over-year to $2.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2.5 million (up 15.5% YoY) and the FY2023 annual result came in at $2.5 million, up 15.5% from the prior year.
• Notes Payables rose to $2.5 million in Q4 2023 per BNTX's latest filing, from $2.3 million in the prior quarter.
• Over five years, Notes Payables peaked at $344.9 million in Q4 2021 and troughed at $2.1 million in Q4 2022.
• A 5-year average of $167.1 million and a median of $197.4 million in 2022 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2021 and 2022: Notes Payables jumped 3078.92% in 2021, then tumbled 99.38% in 2022.
• Over 5 years, Notes Payables stood at $76.3 million in 2019, then plunged by 85.77% to $10.8 million in 2020, then surged by 3078.92% to $344.9 million in 2021, then sank by 99.38% to $2.1 million in 2022, then climbed by 15.5% to $2.5 million in 2023.
• According to Business Quant data, Notes Payables over the past three periods registered $2.5 million, $2.3 million, and $2.1 million for Q4 2023, Q1 2023, and Q4 2022 respectively.